Heparin interactions with apoA1 and SAA in inflammation-associated HDL

Biochemical and Biophysical Research Communications

Volumn 474, Issue 2, 2016, Pages 309-314

  Digre, Andreas ^a   Nan, Jie ^b   Frank, Martin ^c   Li, Jin Ping ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c BIOGNOS AB   (Sweden)

Author keywords

Amyloid; Atherosclerosis; Heparan sulfate; Lipoproteins receptors; Mass spectrometry; Proteoglycans

Indexed keywords

APOLIPOPROTEIN A1; HEPARIN; HIGH DENSITY LIPOPROTEIN; SERUM AMYLOID A; PROTEIN BINDING;

ANIMAL EXPERIMENT; ARTICLE; DRUG PROTEIN BINDING; GEL ELECTROPHORESIS; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MASS SPECTROMETRY; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; ANIMAL; BLOOD; C57BL MOUSE; METABOLISM;

ANIMALS; APOLIPOPROTEIN A-I; HEPARIN; INFLAMMATION; LIPOPROTEINS, HDL; MICE; MICE, INBRED C57BL; PROTEIN BINDING; SERUM AMYLOID A PROTEIN;

EID: 84964575149     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.04.092     Document Type: Article

References (27)

1. J.D. Sipe Amyloidosis Annu. Rev. Biochem. 61 1992 947 975
2. A.D. Snow, J. Willmer, and R. Kisilevsky A close ultrastructural relationship between sulfated proteoglycans and AA amyloid fibrils Lab. Invest. 57 1987 687 698
3. G.T. Westermark, B. Norling, and P. Westermark Fibronectin and basement membrane components in renal amyloid deposits in patients with primary and secondary amyloidosis Clin. Exp. Immunol. 86 1991 150 156
4. X. Zhang, and J.P. Li Heparan sulfate proteoglycans in amyloidosis Prog. Mol. Biol. Transl. Sci. 93 2010 309 334
5. A.G. Holleboom, L. Jakulj, R. Franssen, J. Decaris, M. Vergeer, J. Koetsveld, J. Luchoomun, A. Glass, M.K. Hellerstein, J.J. Kastelein, G.K. Hovingh, J.A. Kuivenhoven, A.K. Groen, S.M. Turner, and E.S. Stroes In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1 J. Lipid Res. 54 2013 1964 1971
6. P. Mangione, M. Sunde, S. Giorgetti, M. Stoppini, G. Esposito, L. Gianelli, L. Obici, L. Asti, A. Andreola, P. Viglino, G. Merlini, and V. Bellotti Amyloid fibrils derived from the apolipoprotein A1 Leu174Ser variant contain elements of ordered helical structure Protein Sci. 10 2001 187 199
7. K. Kuwabara, K. Nishitsuji, K. Uchimura, S.C. Hung, M. Mizuguchi, H. Nakajima, S. Mikawa, N. Kobayashi, H. Saito, and N. Sakashita Cellular interaction and cytotoxicity of the iowa mutation of apolipoprotein A-I (ApoA-IIowa) amyloid mediated by sulfate moieties of heparan sulfate J. Biol. Chem. 290 2015 24210 24221
8. K.P. McAdam, R.J. Elin, J.D. Sipe, and S.M. Wolff Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation J. Clin. Invest. 61 1978 390 394
9. E.P. Benditt, and N. Eriksen Chemical similarity among amyloid substances associated with long standing inflammation Lab. Invest. 26 1972 615 625
10. C.Y. Han, C. Tang, M.E. Guevara, H. Wei, T. Wietecha, B. Shao, S. Subramanian, M. Omer, S. Wang, K.D. O'Brien, S.M. Marcovina, T.N. Wight, T. Vaisar, M.C. de Beer, F.C. de Beer, W.R. Osborne, K.B. Elkon, and A. Chait Serum amyloid A impairs the antiinflammatory properties of HDL J. Clin. Invest. 126 2016 266 281
11. G.T. Westermark, M. Fandrich, and P. Westermark AA amyloidosis: pathogenesis and targeted therapy Annu. Rev. Pathol. 10 2015 321 344
12. T. Kuroda, N. Tanabe, H. Sato, T. Nakatsue, Y. Wada, S. Murakami, M. Nakano, and I. Narita Distribution of amyloid deposits in the kidneys of a patient with reactive amyloidosis associated with rheumatoid arthritis BMC Res. Notes 6 2013 231
13. L. Bontempini, C. Ghimenton, R. Colombari, M. Malena, P. Iuzzolino, M. Canciani, C. Doglioni, and L. Sbabo Secondary amyloidosis and cystic fibrosis. A morphological and histochemical study of five cases Histol. Histopathol. 2 1987 413 416
14. J.D. Gillmore, L.B. Lovat, M.R. Persey, M.B. Pepys, and P.N. Hawkins Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein Lancet 358 2001 24 29
15. J.P. Li, M.L. Galvis, F. Gong, X. Zhang, E. Zcharia, S. Metzger, I. Vlodavsky, R. Kisilevsky, and U. Lindahl In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis Proc. Natl. Acad. Sci. U. S. A. 102 2005 6473 6477
16. E. Elimova, R. Kisilevsky, and J.B. Ancsin Heparan sulfate promotes the aggregation of HDL-associated serum amyloid A: evidence for a proamyloidogenic histidine molecular switch FASEB J. 23 2009 3436 3448
17. J.J. Aguilera, F. Zhang, J.M. Beaudet, R.J. Linhardt, and W. Colon Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A Biochimie 104 2014 70 80
18. M. Egashira, H. Takase, I. Yamamoto, M. Tanaka, and H. Saito Identification of regions responsible for heparin-induced amyloidogenesis of human serum amyloid A using its fragment peptides Arch. Biochem. Biophys. 511 2011 101 106
19. F. Noborn, J.B. Ancsin, W. Ubhayasekera, R. Kisilevsky, and J.P. Li Heparan sulfate dissociates serum amyloid A (SAA) from acute-phase high-density lipoprotein, promoting SAA aggregation J. Biol. Chem. 287 2012 25669 25677
20. R.J. Havel, H.A. Eder, and J.H. Bragdon The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J. Clin. Invest. 34 1955 1345 1353
21. R. Huang, R.A. Silva, W.G. Jerome, A. Kontush, M.J. Chapman, L.K. Curtiss, T.J. Hodges, and W.S. Davidson Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma Nat. Struct. Mol. Biol. 18 2011 416 422
22. C.B. Jendresen, H. Cui, X. Zhang, I. Vlodavsky, L.N. Nilsson, and J.P. Li Overexpression of heparanase lowers the amyloid burden in amyloid-beta precursor protein transgenic mice J. Biol. Chem. 290 2015 5053 5064
23. M.E. Oskarsson, K. Singh, J. Wang, I. Vlodavsky, J.P. Li, and G.T. Westermark Heparan sulfate proteoglycans are important for islet amyloid formation and islet amyloid polypeptide-induced apoptosis J. Biol. Chem. 290 2015 15121 15132
24. R. Kisilevsky, J.B. Ancsin, W.A. Szarek, and S. Petanceska Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications Amyloid 14 2007 21 32
25. X. Mei, and D. Atkinson Lipid-free apolipoprotein A-I structure: insights into HDL formation and atherosclerosis development Arch. Med. Res. 46 2015 351 360
26. S. Jayaraman, C. Haupt, and O. Gursky Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL J. Lipid Res. 56 2015 1531 1542
27. S.P. Tam, R. Kisilevsky, and J.B. Ancsin Acute-phase-HDL remodeling by heparan sulfate generates a novel lipoprotein with exceptional cholesterol efflux activity from macrophages PLoS One 3 2008 e3867